New Therapeutic Developments in Urothelial Cancer: Clinical Trial Evidence and Expert Guidance
The goal of this activity is to improve the knowledge, confidence, competence, and performance of learners to integrate new agents and recent findings into the treatment of patients with urothelial cancer.
Category
  • Bladder Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
New Approaches to Multiple Myeloma Therapy
The goal of this activity is to increase participants’ competence and performance in applying the best evidence-based, guideline-driven treatment options to optimize the care of patients with multiple myeloma and improve patient outcomes. 
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Optimizing Treatment for Head and Neck Cancers
This presentation includes discussion of the management of HPV-related oropharyngeal cancers, nasopharynx cancer, and recurrent/metastatic head and neck squamous cell carcinoma.
Category
  • Head and Neck Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Assessment and Management of CAR T-Cell Related Toxicities
CAR T-cell products have the ability to completely change the treatment paradigm for hematologic malignancies.  These therapies are associated with life-threatening toxicities that require rapid intervention. Newly published consensus statements to better define and grade these toxicities should be incorporated into clinical practice.
Category
  • Management of Immunotherapy-Related Toxicities
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Sequencing Therapy for Patients with Lung Cancer
The NCCN Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer Panels have recently started identifying and recommending preferred systemic therapy regimens for patients with NSCLC and small cell lung cancer based on clinical data and experience; because these are recent recommendations,
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Recorded Presentation from the NCCN Pharmacy Updates: Novel Treatments for Neuroendocrine Tumors
While there is a brand new treatment option for neuroendocrine tumors, it requires a wide array of practical guidance to be given safely and effectively.  Practitioners need to be well versed in patient eligibility, patient preparation for treatment, dosing, administration, and management of side effects.
Category
  • Neuroendocrine Tumors
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Optimizing Outpatient Care in Hematopoietic Cell Transplant Patients
Educating physicians and oncology nurses about the requirements and advantages of an outpatient HCT program would enable the implementation of this program in their institution and help identify appropriate patients who could benefit from this treatment approach.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Strategies to Reduce Clostridioides Difficile Infection in Hematologic Malignancies
A key component of managing patients with hematologic malignancies, especially those who are HCT recipients, lies in preventing, detecting, and treating C. diff infections by establishing C. diff screening procedures and the appropriate use of anti-infective therapy. Knowledge gained in this arena will support prevention, detection, and timely management of C. diff infections in patients with hematologic malignancies who are HCT recipients.
Category
  • Cancer-related Infections
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Management of Cardiac Complications in Hematologic Malignancies
Continued education for oncology care providers is necessary to promote awareness of the cardiac effects of hematologic malignancies and their treatment so that effective methods of management may be implemented.
Category
  • Supportive Care Topics
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Advances and Innovations in Multiple Myeloma
Health care providers managing the patients with multiple myeloma, including oncology nurses and advanced practice nurses, need to be aware of new information, including best treatment strategy, management of adverse effects and other supportive care measures, and transfer their learnings to patients and other members of the care team.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation

Pages